Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Modica

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Endocrinological Investigation|November 3, 2014
Erratum to: GLP-1: benefits beyond pancreasG Muscogiuri, A Cignarelli, F Giorgino, et al.
Cancer Treatment Reviews|April 23, 2023
Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialistsA La Salvia, R Modica, R E Rossi, et al.
Blood|November 15, 1991
Inactivation of endothelin by polymorphonuclear leukocyte-derived lytic enzymesP Patrignani, A Del Maschio, G Bazzoni, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1996
Renal Na,K-ATPase in genetic hypertensionM Ferrandi, G Tripodi, S Salardi, et al.
American Journal of Hypertension|April 1, 1989
Erythrocyte adducin differential properties in the normotensive and hypertensive rats of the Milan strain. Characterization of spleen adducin m-RNAS Salardi, B Saccardo, G Borsani, et al.
Journal of Endocrinological Investigation|August 10, 2014
GLP-1: benefits beyond pancreasG Muscogiuri, A Cignarelli, F Giorgino, et al.
Journal of Endocrinological Investigation|July 2, 2017
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumorsM Del Prete, A Di Sarno, R Modica, et al.
Journal of Endocrinological Investigation|July 22, 2022
Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal studyR Modica, C Scandurra, N M Maldonato, et al.
Journal of Endocrinological Investigation|January 18, 2022
Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control studyT Feola, G Puliani, F Sesti, et al.
Journal of Endocrinological Investigation|March 2, 2021
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategyR E Rossi, A C Milanetto, V Andreasi, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Endocrinological Investigation|November 3, 2014
Erratum to: GLP-1: benefits beyond pancreasG Muscogiuri, A Cignarelli, F Giorgino, et al.
Cancer Treatment Reviews|April 23, 2023
Targeting neuroendocrine tumors with octreotide and lanreotide: Key points for clinical practice from NET specialistsA La Salvia, R Modica, R E Rossi, et al.
Blood|November 15, 1991
Inactivation of endothelin by polymorphonuclear leukocyte-derived lytic enzymesP Patrignani, A Del Maschio, G Bazzoni, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1996
Renal Na,K-ATPase in genetic hypertensionM Ferrandi, G Tripodi, S Salardi, et al.
American Journal of Hypertension|April 1, 1989
Erythrocyte adducin differential properties in the normotensive and hypertensive rats of the Milan strain. Characterization of spleen adducin m-RNAS Salardi, B Saccardo, G Borsani, et al.
Journal of Endocrinological Investigation|August 10, 2014
GLP-1: benefits beyond pancreasG Muscogiuri, A Cignarelli, F Giorgino, et al.
Journal of Endocrinological Investigation|July 2, 2017
Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumorsM Del Prete, A Di Sarno, R Modica, et al.
Journal of Endocrinological Investigation|July 22, 2022
Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal studyR Modica, C Scandurra, N M Maldonato, et al.
Journal of Endocrinological Investigation|January 18, 2022
Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case-control studyT Feola, G Puliani, F Sesti, et al.
Journal of Endocrinological Investigation|March 2, 2021
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategyR E Rossi, A C Milanetto, V Andreasi, et al.
Pageof 8